CMR Institute

1.800.328.2615
LinkedIn

Executive Leadership

CMR Institute is led by a group of experienced and knowledgeable professionals committed to enhancing patient healthcare through advanced education. CMR Institute’s legacy of educational excellence is continually strengthened by the team’s collective expertise and dedication to innovative learning strategies.

 

Michelle O'Connor

Michelle R. O'Connor, MEd, CMR

President and CEO
moconnor@cmrinstitute.org

 

With more than 20 years of service at CMR Institute, Michelle O'Connor has overseen most every aspect of the organization's contributions to providing healthcare education to the biopharmaceutical industry.

Ms. O'Connor's extensive background in education and healthcare has helped to shape her vision for the company. She has been instrumental in the development and evolution of CMR's product development, to e-learning and mobile delivery of its educational content to improving learning outcomes for client organizations.

She is focused on meeting tomorrow's educational needs of the biopharmaceutical and other life science industries which has expanded CMR Institute from being a niche certification provider to an innovative learning company during the industry's most challenging economic era. Ms. O'Connor received an M.A. in education from Virginia Tech in Curriculum and Instruction with an emphasis in Training and Development.

Board of Directors

The Board of Directors provides invaluable support of the Institute's executive team through strategic planning and fiscal oversight. The board actively supports the Institute's approach to mission achievement through the provision of their insight, endorsement, diversification opportunity introductions, as well as resource expansion as necessary.

 

Anthony D. Slonim

Anthony D. Slonim, MD, DrPH, CPE, FACPE

Chair, Board of Directors
President and Chief Executive Officer, Renown Health

 

Tony Slonim is the President and Chief Executive Officer for Renown Health in Reno, Nevada where he oversees all initiatives supporting the delivery of exceptional patient care. Dr. Slonim brings more than a decade of diverse healthcare experience as a practicing physician, professor, author, and fellow. Prior to joining Renown Health, he served as Chief Medical Officer for Barnabas Health in West Orange, NJ; Chief Medical Officer for Shady Grove Adventist Hospital in Rockville, Maryland; Vice President of Medical Affairs at Carilion Medical Center; and spent eight years at Children's National Medical Center in Washington, DC where he was an attending physician in critical care medicine and held several management positions. Dr. Slonim is currently a Professor of Medicine and Pediatrics, at the Virginia Tech-Carilion School of Medicine and is a Fellow of the American College of Physician Executives and the College of Critical Medicine. During his career, Dr. Slonim has authored more than 45 published manuscripts and 11 books. He completed his Medical Doctorate (MD) program at New York Medical College and his Master's and Doctorate in Administrative Medicine and Health Policy from the George Washington University School of Public Health.

 

Partha Anbil

Partha Anbil, MBA

Director
Principal, The ConfluenceElite Consulting Group, LLC

 

Having more than two decades of blended executive management and executive consulting experience within the health and life sciences industries as a practitioner, Mr. Anbil is a strategic and transformation leader.  Partha currently serves as Executive Advisor with PwC and also as a Principal with The ConfluenceElite Consulting Group. Prior, he was an associate partner in the Strategy & Transformation Practice, Health Care & Life Sciences industry at IBM Global Business Services; Practice Leader at Wolters Kluwer Pharma Solutions; Senior Principal at IMSHealth Management Consulting; Director at KPMG Consulting; and Senior Manager at PricewaterhouseCoopers. Mr. Anbil is a lead faculty and advisory board member for the Institute of Pharmaceutical Management as well as a participant on the editorial advisory board for PM360 Magazine, a premier trade publication for pharma marketers and Managed Care Magazine.

Mr. Anbil received his MBA in Corporate Strategy and Business Development from the MIT Sloan School of Management and an M.S. in Corporate Finance and M.A. in Econometrics from the University of Toledo. He has a Masters in International Business from the Indian Institute of Foreign Trade (IIFT) and a B.E. in Electrical Engineering. Mr. Anbil has multiple certifications in Applied Consultancy Leadership Skills and Consulting Skills by Deloitte & Touché and with the Commonwealth of Pennsylvania, certifications in Briefing Skills, Communication Skills, and Interpersonal Communication Skills.

Partha speaks at numerous industry related conferences and has published many articles in business journals and magazines including PharmExec, PM360, MM&M, PharmaVoice, and Pharmaceutical Commerce, etc.

 

J. Lyle Bootman

J. Lyle Bootman, PhD

Director
Dean, College of Pharmacy
Arizona Health Science Center, University of Arizona

 

Dr. Bootman is Dean for the College of Pharmacy at the University of Arizona Health Sciences Center. He is professor of pharmacy, medicine and public health, and a Fellow of several professional associations including the American Pharmacists Association, American Association of Pharmaceutical Scientists, and the American College of Apothecaries. Lyle is the executive director and founder of the University of Arizona Center for Health Outcomes and PharmacoEconomic (HOPE) Research, one of the first such centers developed in the world. He is former president of the American Pharmacists Association and President Emeritus of the Pharmacy & Therapeutics Society. Dr. Bootman is an elected member of the Institute of Medicine (IOM) of the National Academies, where he currently serves on the Board of Health Care Services, and Co-chair of the IOM Committee which released the highly publicized report, Preventing Medication Errors. He received his pharmacy education at the University of Arizona and his doctorate at the University of Minnesota where he was given the university's highest alumni honor. Dr. Bootman completed a clinical pharmacy residency at the world-renowned National Institutes of Health, and received an honorary doctorate from the University of the Sciences in Philadelphia.

 

George Lutzow

George Lutzow

Director
Owner, LutzowSolutions
Managemen
t & Interim Director Managing Human Capital Program at St. Joseph's University

 

Mr. Lutzow is proprietor of “lutzowsolutions”, an organizational-based consultancy firm focused on developing human capital initiatives, business strategy, leadership and organizational development, and executive coaching that drive performance through engagement to results. With over 30 years of executive business experience with Fortune 50 organizations and his passion for life-long education, George shares his knowledge as an instructor of human resource management MBA programs most recently at St. Joseph’s University and Deleware Valley College. Mr. Lutzow was previously Director of Education at Acme Markets, a division of Supervalu, a leader in grocery, drug, and supply chain operations in the United States. He brings a wealth of experience in human resource practices, training, development, organizational effectiveness, and change management. George is a graduate of Drexel University, in business administration and received his masters in organizational dynamics from University of Pennsylvania.

 

Andre Muelenaer, MD, MS

Andre Muelenaer, Jr., MD, MS

Director
Chief, Section of Pediatric Pulmonology/Allergy, Carilion Clinic
President and Chief Medical Officer, Pediatric Medical Device Institute

 

Dr. Muelenaer remains active in a medical career that now spans 36 years, including 27 years of active and reserve duty in the Army Medical Corps. He is a graduate of Virginia Tech, with a BS in Biology and MS in zoology. He received his medical degree from the Eastern Virginia Medical School. His general pediatric training was at William Beaumont Army Medical Center, and pediatric pulmonology fellowship at the University of North Carolina, Chapel Hill. He holds academic appointments at the Virginia Tech Carilion School of Medicine, Virginia Tech-Wake Forest University School of Biomedical Engineering and Science, and the University of Virginia. He is board certified in pediatrics and pediatric pulmonology. He has held leadership positions as division chief of pediatric pulmonology/gastroenterology at Duke University, and division chief of pediatric pulmonology/allergy at Carilion Clinic Children’s Hospital.    

Andy has served as a medical consultant for CitiHope International since 2004, supporting missions on a global basis. He has traveled on behalf of CitiHope to Kyrgyzstan, South Africa, Zimbabwe, Malawi, Zambia, Ghana, and Morocco performing needs assessments, teaching, and serving as medical liaison for multi-disciplinary professional humanitarian and medical relief teams. He coordinated medical communications with hospitals in Louisiana as CitiHope provided one of the earliest responses to the hurricane Katrina disaster. This included a primary needs assessment and identification of resources, then assistance in the logistics of moving medicines, supplies, and medical personnel to Baton Rouge via volunteer aircraft. He then participated in the secondary response related to more long term needs such as vaccination programs, and sustained supply of medications and disposable medical supplies.

In addition to his clinical activities, Dr. Muelenaer has supported the advancement of medical technology on a global basis, first as the medical director of the Carilion Biomedical Institute, and now as co-founder, president, and chief medical officer of the Pediatric Medical Device Institute. He maintains a telemedical practice in Raleigh, North Carolina, and serves as part-time medical director for several biotechnology companies in Virginia. He has served on the board of directors of non-profit medical advocacy and service organizations.

 

George Lutzow

Mark Sorrentino, MD, MS

Director
Executive Medical Director, Global Product Development, PPD Inc.
Former Chief Medical Officer, ADMA Biologics

 

Dr. Sorrentino has over 15 years experience in the pharmaceutical and biotech industries. He is currently the Executive Medical Director, Global Product Development, at PPD Inc, and is responsible for support of pharmaceutical development consulting services focusing on biologics development and post approval strategies. 

Prior to joining PPD, Mark was the global Chief Medical Officer at ADMA Biologics where he oversaw all clinical development operations. Prior to ADMA, he was the Director, Medical Science at MedImmune where he had primary responsibility for development and oversight of numerous Phase IV and post-marketing studies across several therapeutic areas including infectious diseases, respiratory diseases, and transplant medicine, and worked closely with the sales and marketing teams.

Dr. Sorrentino has also served as a consultant to biotechnology firms and has overseen implementation of medical information systems. Dr. Sorrentino received his MD as well as an MS in Clinical Nutrition from the Chicago Medical School. He completed both a residency in Pediatrics and fellowship in Pediatric Critical Care at Children’s National Medical Center in Washington DC and currently holds an appointment as a Assistant Clinical Professor at the George Washington University School of Medicine. Dr. Sorrentino was an attending physician in the CNMC pediatric intensive care unit for eight years and participated in numerous Industry sponsored critical care trials.  

Holding active medical licenses in Washington DC and Maryland, Dr. Sorrentino also serves as the Medical Director for all Susan G. Komen events in the DC area and has volunteered on several international medical missions. 

 

Clara Anne Spencer

Clara Anne Spencer, RPh

Director
Director of Pharmacy Contracting, Carilion Clinic

 

Clara Anne Spencer is a registered pharmacist and has worked as the Director of Pharmacy Contracting for Carilion Clinic since March 2000. During this time, her work has included system-wide pharmacy contracting, maximizing Premier Group Purchasing agreements and capital project initiatives, as well as direct improvements to patient care through the implementation of a Patient Medication Assistance progam. Ms. Spencer serves on the Clinical Products Committee, Surgical Products Committee, and coordinates the Pharmacy Leadership Team.

Prior to her joining Carilion Clinic, Clara Anne had ample experience working with all sides of practical healthcare as a Healthcare Resource Management Director for Premier, Inc., and Director of Pharmacy for Lewis Gale Psychiatric Pavilion. Her background includes hospital pharmacy practice in both for-profit and not-for-profit settings, retail pharmacy, and serving as regional director for a group purchasing organization.

In addition, Clara Anne serves on the Board of Directors for the Bradley Free Clinic.

 

Jeffrey L. Thomas

Jeffrey Thomas

Director
CEO, Silver Fox Consultants, LLC

 

Mr. Thomas is the CEO of Silver Fox Consultants, a pharmaceutical and medical device consulting firm specializing in all areas of product commercialization from Phase 3A through life cycle management. With a long history as a former pharmaceutical c-suite executive within several multi-billion dollar organizations, Jeff leads with experience and results.

As the former Chief Commercial Officer, PuraCap Pharmaceuticals, Mr. Thomas led commercial strategy and development to ensure PuraCap's integrated commercial success. Prior, he was Vice President of Corporate Customers, Customer Marketing and Strategic Alliances at Novartis where he managed high-stake pharmaceutical sales and marketing departments and programs. During his tenure as US President of Ranbaxy, the largest Indian Pharmaceutical company, he had full profit and loss responsibilities for building the branded products group in North America – launching four products in the first full year of operation. With inVentiv Health, as President of the Strategy and Analytics group, Mr. Thomas was responsible for strategic planning and financial performance for four companies that made up the consultancy arm of inVentiv. He built the Ventiv Access Group, a company that provided managed markets services for client portfolios including emerging through the top 10 pharmaceutical and biotech companies with a focus on product launch lifecycle management.

Mr. Thomas earned a Bachelor of Science degree in Economics from West Liberty State College in West Virginia. He also serves on the Advisory Board for the Healthcare Businesswomen's Association, Metro Chapter.

 

Jeff Mackie

Jeff Mackie, PhD

Chairman Emeritus
Retired Ambassador, GlaxoSmithKline Pharmaceuticals

 

Jeff Mackie is a retired 20-year veteran of GlaxoSmithKline Pharmaceuticals. He joined GSK in 1982 and held positions as Medical Science Liaison and Training and Development Department Director. In recognition of his ability to motivate patients to be more involved in their own care, GSK honored Dr. Mackie by naming him their "Ambassador to the Healthcare Community." In that role, he traveled the United States speaking to healthcare professionals and their patients helping them understand how best to motivate patients to be more active participants in their own care.

Currently, Dr. Mackie is President of Mackie and Associates. He is a professional speaker/motivating humorist specializing in the healthcare industry. He is a registered pharmacist and a former professor at the Massachusetts College of Pharmacy and Health Sciences. He is a member of the American Pharmacists Association and an Emeritus Member of the National Speakers Association. Dr. Mackie holds a doctorate in Pharmacy and Toxicology from Temple University.

 

Donald Stark

Donald Stark

Director Emeritus

Don Stark has extensive experience serving the pharmaceutical industry in various roles including Chairman, CEO, and President of Nova Pharmaceutical Corporation; President of Sandoz Japan; President of Sandoz, USA; President of Sterling Drug Pharmaceutical Group; Founding Member and Vice Chairman of Nova; and Director of MicroCarb, Business Advisor to Medical Science Partners created by Harvard Medical School. Mr. Stark has served as Treasurer of the American Foundation for Pharmaceutical Education; on advisory committees for Farleigh Dickinson University and the National Wholesale Druggists Association; as a Trustee of Lakeland College; on the Science Center Committee of Drake University, and as a member of the CMR Institute Strategic Advisory Board. Mr. Stark holds a Master's Degree in Science in Education from Drake University, where he received an Alumni Achievement Award.